Skip to contentI
Intelligent Bio Solutions Inc.
I
INBSIntelligent Bio Solutions Inc. Q3 2024 · 10-Q
Revenue$823.80K$823.80K+80.2% vs Q3 2023 Net Income-$2.98M-$2.98MN/M vs Q3 2023 EPS Diluted-$1.43-$1.43N/M vs Q3 2023 Gross Profit$178,489+440.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,446,564N/M Margins · derivedGross margin21.7%+14.4 pt vs Q3 2023
Operating margin-358.6%+1073.1 pt vs Q3 2023
Net margin-361.5%+1026.5 pt vs Q3 2023
ended Mar 31, 2024 · filed May 8, 2024 · 38 d after period end